Malondialdehyde anticorps

N° du produit ABIN335417

Il existe 1 publication pour ce produit. L’anticorps anti-Malondialdehyde Monoclonal Souris est utilisé pour la détection de Malondialdehyde. Il a été validé pour IHC.

Aperçu rapide pour Malondialdehyde anticorps (ABIN335417)

Antigène: Malondialdehyde (MDA)

Reactivité: Veuillez nous consulter SVP

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Malondialdehyde est non-conjugé

Application: Immunohistochemistry (IHC)

Clone: 1F83

Détail du produit anti-Malondialdehyde anticorps

Specificité: Specific for MDA modified protein (especially DHP-lysine) in all species.

Purification: Protein A purified

Immunogène: MDA-modified Keyhole-Limpet Hemocyanin.

Isotype: IgG2a lambda

Information d'application

Indications d'application: IHC: Suggested concentration is 0.5-1.0 ug/mL on paraformaldehyde fixed tissue.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid:100 ug IgG/mL in 10 mM PBS containing 0.1 % NaN 3 and 0.1 % BSA.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Références pour anticorps anti-Malondialdehyde (ABIN335417)

Yamada, Kumazawa, Ishii, Nakayama, Itakura, Shibata, Kobayashi, Sakai, Osawa, Uchida: "Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine." dans: Journal of lipid research, Vol. 42, Issue 8, pp. 1187-96, (2001) (PubMed).

Détails sur Malondialdehyde

Antigène: Malondialdehyde (MDA)

Autre désignation: Malondialdehyde / MDA

Classe de substances: Chemical

Sujet: Malondialdehyde (MDA) is one of the major aldehyde derive from lipid peroxidation. MDA is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with MDA and lysine residue leads to the formation of numerous numbers of adducts, such as dihydropyridine-lysine (DHP-lysine) type derivative. This monoclonal antibody is specific for the MDA-modified protein, especially DHP-lysine type derivative.